Armata Pharmaceuticals (ARMP) Payables (2013 - 2026)

Armata Pharmaceuticals (ARMP) has 14 years of Payables data on file, last reported at $660000.0 in Q1 2026.

• For the quarter ending Q1 2026, Payables fell 32.72% year-over-year to $660000.0; the trailing twelve-month figure through Mar 2026 stood at $660000.0 (down 32.72% YoY), and the FY2025 full-year result was $1.7 million, down 17.03% from the prior year.
• Payables fell to $660000.0 in Q1 2026, from $1.7 million in the prior quarter.
• In the past five years, Payables ranged from a high of $37.4 million in Q1 2023 to a low of $332000.0 in Q3 2024.
• A 5-year average of $6.5 million and a median of $2.1 million in 2024 frame the typical range for Payables.
• Across the five-year window, Payables jumped 987.81% in 2023 and slumped 95.04% in 2024, its largest moves.
• Tracing ARMP's Payables over 5 years: stood at $1.7 million in 2022, then declined by 5.54% to $1.6 million in 2023, then grew by 29.65% to $2.1 million in 2024, then slipped by 17.03% to $1.7 million in 2025, then slumped by 61.29% to $660000.0 in 2026.
• Business Quant data shows ARMP's Payables at $660000.0 in Q1 2026, $1.7 million in Q4 2025, and $582000.0 in Q3 2025.